Furthermore, an advanced tumor stage, such as stage IV (HR: 3.406; 95% CI: 2.787–4.163; p value < 2 × 10−16) and stage III (HR: 1.874; 95% CI: 1.546–2.272; p value = 1.69 × 10−10), a high level of immuno-suppressive cytokines (HR: 1.165; 95% CI: 1.001–1.356; p value = 0.048), and TP53 mutation (HR: 1.322; 95% CI:1.138–1.535; p value = 0.000255) were all associated with poorer overall survival. Here, TP53 is linked to neoplasm.